Vicarious Surgical (NYSE:RBOT) Given New $8.50 Price Target at Piper Sandler

Vicarious Surgical (NYSE:RBOTFree Report) had its price objective cut by Piper Sandler from $10.50 to $8.50 in a report released on Tuesday,Benzinga reports. They currently have a neutral rating on the stock.

Vicarious Surgical Stock Down 14.9 %

Shares of RBOT stock opened at $8.20 on Tuesday. The firm has a market capitalization of $48.42 million, a P/E ratio of -0.80 and a beta of 1.35. Vicarious Surgical has a twelve month low of $4.27 and a twelve month high of $19.00. The stock’s fifty day simple moving average is $12.56 and its 200 day simple moving average is $10.60.

Vicarious Surgical (NYSE:RBOTGet Free Report) last issued its quarterly earnings data on Monday, March 17th. The company reported ($2.43) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.69) by $0.26. The firm had revenue of $2.09 million for the quarter. During the same quarter in the prior year, the company earned ($2.25) EPS. As a group, equities research analysts expect that Vicarious Surgical will post -10.89 EPS for the current fiscal year.

Institutional Investors Weigh In On Vicarious Surgical

A number of institutional investors have recently made changes to their positions in the stock. Renaissance Technologies LLC grew its position in shares of Vicarious Surgical by 11.6% in the 4th quarter. Renaissance Technologies LLC now owns 11,534 shares of the company’s stock valued at $152,000 after buying an additional 1,200 shares during the last quarter. Geode Capital Management LLC grew its position in shares of Vicarious Surgical by 8.2% in the 4th quarter. Geode Capital Management LLC now owns 30,799 shares of the company’s stock valued at $405,000 after buying an additional 2,336 shares during the last quarter. Finally, DnB Asset Management AS grew its position in shares of Vicarious Surgical by 21.1% in the 4th quarter. DnB Asset Management AS now owns 21,213 shares of the company’s stock valued at $279,000 after buying an additional 3,692 shares during the last quarter. Institutional investors own 47.27% of the company’s stock.

Vicarious Surgical Company Profile

(Get Free Report)

Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.

See Also

Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.